{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:01:17Z","timestamp":1774461677883,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["FN 310000-110058"],"award-info":[{"award-number":["FN 310000-110058"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10557-019-06887-9","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T08:02:52Z","timestamp":1561968172000},"page":"407-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of PDE-5 Inhibition on the Cardiopulmonary System After 2 or 4\u00a0Weeks of Chronic Hypoxia"],"prefix":"10.1007","volume":"33","author":[{"given":"Coline","family":"Nydegger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio F.","family":"Corno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig K.","family":"von Segesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Beghetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Samaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Milano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"issue":"11","key":"6887_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027910","volume":"6","author":"G Milano","year":"2011","unstructured":"Milano G, Bianciardi P, Rochemont V, Vassalli G, Segesser LK, Corno AF, et al. Phosphodiesterase-5 inhibition mimics intermittent reoxygenation and improves cardioprotection in the hypoxic myocardium. PLoS One. 2011;6(11):e27910.","journal-title":"PLoS One"},{"issue":"6","key":"6887_CR2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1159\/000196718","volume":"64","author":"M Samaja","year":"1997","unstructured":"Samaja M. Blood gas transport at high altitude. Respiration. 1997;64(6):422\u20138.","journal-title":"Respiration."},{"key":"6887_CR3","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2015.00071","volume":"3","author":"RL van Loon","year":"2015","unstructured":"van Loon RL, Bartelds B, Wagener FA, Affara N, Mohaupt S, Wijnberg H, et al. Erythropoietin attenuates pulmonary vascular remodeling in experimental pulmonary arterial hypertension through interplay between endothelial progenitor cells and Heme oxygenase. Front Pediatr. 2015;3:71.","journal-title":"Front Pediatr"},{"key":"6887_CR4","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.2174\/092986707781058823","volume":"14","author":"M Guazzi","year":"2007","unstructured":"Guazzi M, Samaja M. The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development. Curr Med Chem. 2007;14:1893\u2013910.","journal-title":"Curr Med Chem"},{"key":"6887_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2015.00012","volume":"3","author":"SL Siehr","year":"2015","unstructured":"Siehr SL, McCarthy EK, Ogawa MT, Feinstein JA. Reported sildenafil side effects in pediatric pulmonary hypertension patients. Front Pediatr. 2015;3:12.","journal-title":"Front Pediatr"},{"issue":"19","key":"6887_CR6","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1161\/CIRCULATIONAHA.113.005698","volume":"129","author":"RJ Barst","year":"2014","unstructured":"Barst RJ, Beghetti M, Pulido T, Layton G, Konourina I, Zhang M, et al. STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension. Circulation. 2014;129(19):1914\u201323.","journal-title":"Circulation."},{"issue":"2","key":"6887_CR7","first-page":"131","volume":"10","author":"RI Negoi","year":"2017","unstructured":"Negoi RI, Ghiorghiu I, Filipoiu F, Hostiuc M, Negoi I, Ginghina C. Severe pulmonary arterial hypertension associated with congenital cardiac shunts: evolution under specific treatment. J Med Life. 2017;10(2):131\u20138.","journal-title":"J Med Life"},{"issue":"10","key":"6887_CR8","first-page":"570","volume":"71","author":"C Zhou","year":"2016","unstructured":"Zhou C, Guo X, Cui Q, Liu X, Su G, Zhang J. Sildenafil improves the function of endothelial cells in patients suffering from congenital heart disease with pulmonary hypertension. Pharmazie. 2016;71(10):570\u20134.","journal-title":"Pharmazie."},{"key":"6887_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijcard.2016.06.322","volume":"221","author":"H Mori","year":"2016","unstructured":"Mori H, Park IS, Yamagishi H, Nakamura M, Ishikawa S, Takigiku K, et al. Sildenafil reduces pulmonary vascular resistance in single ventricular physiology. Int J Cardiol. 2016;221:122\u20137.","journal-title":"Int J Cardiol"},{"issue":"25","key":"6887_CR10","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","volume":"62","author":"W Seeger","year":"2013","unstructured":"Seeger W, Adir Y, Barbera JA, Champion H, Coghlan JG, Cottin V, et al. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol. 2013;62(25 Suppl):D109\u201316.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"6887_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1183\/09031936.00139914","volume":"46","author":"D Dominguez-Fandos","year":"2015","unstructured":"Dominguez-Fandos D, Valdes C, Ferrer E, Puig-Pey R, Blanco I, Tura-Ceide O, et al. Sildenafil in a cigarette smoke-induced model of COPD in the guinea pig. Eur Respir J. 2015;46(2):346\u201354.","journal-title":"Eur Respir J"},{"issue":"2","key":"6887_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.healun.2016.04.010","volume":"36","author":"P Vitulo","year":"2017","unstructured":"Vitulo P, Stanziola A, Confalonieri M, Libertucci D, Oggionni T, Rottoli P, et al. Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: a randomized controlled multicenter clinical trial. J Heart Lung Transplant. 2017;36(2):166\u201374.","journal-title":"J Heart Lung Transplant"},{"key":"6887_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fphys.2018.00289","volume":"9","author":"C Nydegger","year":"2018","unstructured":"Nydegger C, Martinelli C, Di Marco F, Bulfamante G, von Segesser L, Tozzi P, et al. Phosphodiesterase-5 inhibition alleviates pulmonary hypertension and basal Lamina thickening in rats challenged by chronic hypoxia. Front Physiol. 2018;9:289.","journal-title":"Front Physiol"},{"issue":"5","key":"6887_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/jcmm.13026","volume":"21","author":"S Favre","year":"2017","unstructured":"Favre S, Gambini E, Nigro P, Scopece A, Bianciardi P, Caretti A, et al. Sildenafil attenuates hypoxic pulmonary remodelling by inhibiting bone marrow progenitor cells. J Cell Mol Med. 2017;21(5):871\u201380","journal-title":"J Cell Mol Med"},{"issue":"6","key":"6887_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0002-9149(02)02586-9","volume":"90","author":"JJ Lepore","year":"2002","unstructured":"Lepore JJ, Maroo A, Pereira NL, Ginns LC, Dec GW, Zapol WM, et al. Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. Am J Cardiol. 2002;90(6):677\u201380.","journal-title":"Am J Cardiol"},{"issue":"1","key":"6887_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1164\/rccm.200302-282OC","volume":"169","author":"RT Schermuly","year":"2004","unstructured":"Schermuly RT, Kreisselmeier KP, Ghofrani HA, Yilmaz H, Butrous G, Ermert L, et al. Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. Am J Respir Crit Care Med. 2004;169(1):39\u201345.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"6887_CR17","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1378\/chest.127.5.1647","volume":"127","author":"JJ Lepore","year":"2005","unstructured":"Lepore JJ, Maroo A, Bigatello LM, Dec GW, Zapol WM, Bloch KD, et al. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest. 2005;127(5):1647\u201353.","journal-title":"Chest."},{"issue":"4","key":"6887_CR18","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/hc2901.093117","volume":"104","author":"L Zhao","year":"2001","unstructured":"Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, et al. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation. 2001;104(4):424\u20138.","journal-title":"Circulation."},{"issue":"4","key":"6887_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jamcollsurg.2004.06.003","volume":"199","author":"JM Lyons","year":"2004","unstructured":"Lyons JM, Duffy JY, Wagner CJ, Pearl JM. Sildenafil citrate alleviates pulmonary hypertension after hypoxia and reoxygenation with cardiopulmonary bypass. J Am Coll Surg. 2004;199(4):607\u201314.","journal-title":"J Am Coll Surg"},{"issue":"8","key":"6887_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrd2030","volume":"5","author":"HA Ghofrani","year":"2006","unstructured":"Ghofrani HA, Osterloh IH, Grimminger F. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov. 2006;5(8):689\u2013702.","journal-title":"Nat Rev Drug Discov"},{"issue":"22","key":"6887_CR21","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.jacc.2007.07.078","volume":"50","author":"M Guazzi","year":"2007","unstructured":"Guazzi M, Samaja M, Arena R, Vicenzi M, Guazzi MD. Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol. 2007;50(22):2136\u201344.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"6887_CR22","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.106.624544","volume":"115","author":"D Penaloza","year":"2007","unstructured":"Penaloza D, Arias-Stella J. The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness. Circulation. 2007;115(9):1132\u201346.","journal-title":"Circulation."},{"issue":"1","key":"6887_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/icvts\/ivu097","volume":"19","author":"TM Gorter","year":"2014","unstructured":"Gorter TM, van Melle JP, Hillege HL, Pieper PG, Ebels T, Hoendermis ES, et al. Ventricular remodelling after pulmonary valve replacement: comparison between pressure-loaded and volume-loaded right ventricles. Interact Cardiovasc Thorac Surg. 2014;19(1):95\u2013101.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"3","key":"6887_CR24","doi-asserted-by":"publisher","first-page":"H361","DOI":"10.1152\/ajpheart.00843.2013","volume":"307","author":"MA Borgdorff","year":"2014","unstructured":"Borgdorff MA, Bartelds B, Dickinson MG, van Wiechen MP, Steendijk P, de Vroomen M, et al. Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload. Am J Physiol Heart Circ Physiol. 2014;307(3):H361\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"6887_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.118.035326","volume":"139","author":"S Andersen","year":"2019","unstructured":"Andersen S, Nielsen-Kudsk JE, Vonk Noordegraaf A, de Man FS. Right ventricular fibrosis. Circulation. 2019;139(2):269\u201385.","journal-title":"Circulation."},{"key":"6887_CR26","doi-asserted-by":"publisher","unstructured":"Crnkovic S, Egemnazarov B, Damico R, Marsh LM, Nagy BM, Douschan P, et al. Disconnect between fibrotic response and right ventricular dysfunction. Am J Respir Crit Care Med. 2018. \n                    https:\/\/doi.org\/10.1164\/rccm.201809-1737OC\n                    \n                  .","DOI":"10.1164\/rccm.201809-1737OC"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-019-06887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-019-06887-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-019-06887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T23:16:16Z","timestamp":1593472576000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-019-06887-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["6887"],"URL":"https:\/\/doi.org\/10.1007\/s10557-019-06887-9","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"1 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health (NIH Publication No. 85-23, Revised 1996). Experimental protocols conformed to Swiss law. The local ethical committee for animal research (Service de la Consommation et des Affaire V\u00e9t\u00e9rinaires, SCAV) approved the protocol (authorization VD2467).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}